BiologicsMD, Inc. Awards Manufacturing Contract to Cytovance Biologics Inc.. to Expand Development of Breakthrough Osteoporosis Medication

Published: Jun 12, 2012

FAYETTEVILLE, Ark.--(BUSINESS WIRE)--BiologicsMD, a drug development company based in Fayetteville, AR, awarded a manufacturing contract to Cytovance Biologics, Inc. located in Oklahoma City, OK, to continue development of BiologicMD’s breakthrough osteoporosis medication, PTH-CBD™. The agreement will lead to the development of the manufacturing platform for PTH-CBD™, a key step in the process that will allow BiologicsMD to conduct Phase I studies.

Back to news